2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Purity ≥98.0% (HPLC)

Tsanangudzo Pfupi

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene

CAS: 1030825-20-7

Chitarisiko: White kana Off-White Powder

Kuchena: ≥98.0% (HPLC)

Pakati pe API (CAS: 842133-18-0) mukurapa Type 2 Diabetes Mellitus

Inquiry: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Manufacturer Supply Related Intermediates:
4-Fluorophenylboronic Acid CAS: 1765-93-1
2-(4-Fluorophenyl)thiophene CAS: 58861-48-6
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS: 32384-65-9
5-Iodo-2-Methylbenzoic Acid CAS 54811-38-0
2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS: 898566-17-1
CAS: 842133-18-0
CAS: 928672-86-0

Chemical Properties:

Chemical Name	2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
Nhamba yeCAS	1030825-20-7
Nhamba yeCAT	RF-PI234
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Mazana emaKilogram
Molecular Formula	C18H14BrFS
Molecular Weight	361.27
Melting Point	103 ℃
Density	1.388
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	White kana Off-White Powder
Kuchena / Analysis Method	≥98.0% (HPLC)
Kurasika paKuomesa	≤1.00%
Residue pamoto	≤0.50%
Heavy Metals	≤20ppm
Test Standard	Enterprise Standard
Usage	Yepakati pe API (CAS: 842133-18-0)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza & mwando

Zvakanakira:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi we2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene (CAS: 1030825-20-7) ine mhando yepamusoro.Itiri yepakati kazhinji mune synthesis yeAPI (CAS: 461432-26-8).API (CAS: 461432-26-8) mushonga mutsva weantidiabetic wakagadzirwa pamwe chete neBristol-Myers Squibb neAstraZeneca, uchibvumidzwa neEuropean Medicines Agency (EMA) muna Mbudzi 12, 2012. Ndiyo zvakare yekutanga kubvumidzwa SGLT2 inhibitor ye kurapwa kwechirwere cheshuga chechipiri, kuva sarudzo inokosha mukurapa kwechirwere cheshuga, uye inoshandiswa kuvandudza glycemic control sechigadziro chekudya uye kurovedza muviri kune vanhu vakuru vane chirwere cheshuga chechipiri.